FBN1 and Marfan syndrome: When abnormal Fbn-1 was first identified as the cause of Marfan syndrome in 1991 (Dietz et al., 1991), it was believed that the coding mutations resulted in a structural weakness of microfibrils (Matt et al., 2008), leading to arterial wall “weakness” and the syndrome's vascular manifestations.